1. Home
  2. TTEK vs PCVX Comparison

TTEK vs PCVX Comparison

Compare TTEK & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tetra Tech Inc.

TTEK

Tetra Tech Inc.

HOLD

Current Price

$27.15

Market Cap

7.9B

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$52.11

Market Cap

7.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTEK
PCVX
Founded
1966
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
7.0B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
TTEK
PCVX
Price
$27.15
$52.11
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$44.00
$88.25
AVG Volume (30 Days)
3.8M
1.3M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
0.82%
N/A
EPS Growth
N/A
N/A
EPS
0.76
N/A
Revenue
$2,964,148,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.43
N/A
P/E Ratio
$36.00
N/A
Revenue Growth
7.66
N/A
52 Week Low
$25.81
$29.10
52 Week High
$43.14
$65.00

Technical Indicators

Market Signals
Indicator
TTEK
PCVX
Relative Strength Index (RSI) 40.98 55.11
Support Level $26.98 $44.85
Resistance Level $34.83 $52.00
Average True Range (ATR) 0.97 2.11
MACD 0.08 0.80
Stochastic Oscillator 16.34 77.69

Price Performance

Historical Comparison
TTEK
PCVX

About TTEK Tetra Tech Inc.

Tetra Tech Inc provides consulting and engineering services for environmental, infrastructure, resource management, energy, and international development markets. It specializes in providing water-related services for public and private clients. It designs infrastructure, facilities, and other structures with complex plans and resource management. it has two reportable segments. Its Government Services Group (GSG) segment includes activities with U.S. government clients (federal, state and local) and activities with development agencies world-wide. Commercial/International Services Group (CIG) segment, which derives maximum revenue, includes activities with U.S. commercial clients and international clients other than development agencies.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: